ARCHIVES

DCT Board Okays Recompetitions

This article is from The Cancer Letter archive.

Vol. 11 No. 25 | June 21, 1985

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends End of Life Discussions

January 28, 2011

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000